Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

NCT06626893 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Parma as lead sponsor.

NCT NCT06626893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2022
Completion date
March 1, 2025
Enrollment
100 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphoblastic, myeloid leukemia, acute